New Haven Biotech Exits Big Winstanley Project
A biotech company agreed to pay $41.5 million to terminate its lease at Winstanley Enterprises’s 101 College St. lab development in New Haven.
by Steve Adams | Aug 23, 2024 | Commercial & Industrial, CR Daily, Executive Briefing
A biotech company agreed to pay $41.5 million to terminate its lease at Winstanley Enterprises’s 101 College St. lab development in New Haven.
We're sorry, it appears you don't have the proper subscription to view this page. Please click the button below to purchase or renew your subscription and gain access to this content.
Questions? Please contact us at 617.896.5367, or send us an email at subscriptions@thewarrengroup.com.
It appears someone has logged in to your account from another device. Please click the button below to log back in on this device, and terminate all other sessions.
Questions? Please contact us at 617.896.5367, or send us an email at subscriptions@thewarrengroup.com.
Already have a subscription?
Need a subscription?
Just looking for the headlines?
If you need assistance with your subscription, please visit our customer service form or email customerservice@thewarrengroup.com.